SCHEMBL30798199

SCHEMBL30798199

COCCn1c(CCl)nc2ccc(C(=O)OC)nc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
GLP1R P43220 1/20 0.39
TLR7 Q9NYK1 1/20 0.38
GAA P10253 4/20 0.38
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 3/20 0.38
LMNA P02545 3/20 0.38
MEN1 O00255 3/20 0.38
PKM P14618 2/20 0.38
HPGD P15428 2/20 0.38
HTT P42858 2/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
USP2 O75604 1/20 0.38
MAPT P10636 1/20 0.38
ADORA2A P29274 2/20 0.37
PTGER4 P35408 1/20 0.37
GLA P06280 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25544377 0.83 PPARG (0.45) TP53ALDH1A1KMT2AKDM4EMEN1
SCHEMBL23980785 0.81 PTGER4 (0.36) TP53TLR7GAAALDH1A1KDM4E
SCHEMBL31143304 0.80 MAPT (0.38) TP53GAAALDH1A1KMT2AKDM4E
SCHEMBL31143242 0.80 MAPT (0.38) TP53GAAALDH1A1KMT2AKDM4E
SCHEMBL20280071 0.78 GLP1R (0.42) GLP1RGAAALDH1A1KMT2AKDM4E
SCHEMBL29480799 0.78 GLP1R (0.42) GLP1RGAAALDH1A1KMT2AKDM4E
SCHEMBL20288189 0.78 GLP1R (0.42) GLP1RGAAALDH1A1KMT2AKDM4E
SCHEMBL29480797 0.78 GLP1R (0.42) GLP1RGAAALDH1A1KMT2AKDM4E
SCHEMBL30259555 0.78 GLP1R (0.41) GLP1RGAAALDH1A1KMT2AKDM4E
SCHEMBL29924291 0.78 PTGER4 (0.35) MAPTPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024028795-A1 HETEROBICYCLIC COMPOUNDS AS ORAL GLP1R AGONISTS ZYDUS LIFESCIENCES LIMITED (IN) 2024-02-08 WO disclosed